TGF-beta and IL-10 Production by HIV-specific CD8+ T Cells is Regulated by CTLA-4 Signaling on CD4+ T Cells
Overview
Authors
Affiliations
Immune dysregulation in HIV-1 infection is associated with increased expression of inhibitory molecules such as CTLA-4, TGF-beta, and IL-10. In this study we examined one potential mechanism for regulating TGF-beta and IL-10 expression by HIV-specific suppressor CD8+ T cells. No overlap between TGF-beta, IL-10, and IFN-gamma cytokine production by HIV-specific CD8+ T cells was observed. TGF-beta positive and IL-10 positive cells were FOXP3 negative, CD25 negative, and displayed a heterogeneous surface expression of CD127. TGF-beta and IL-10 positive CD8+ T cells did not express CTLA-4. Nevertheless, CTLA-4 blockade resulted in a significant decrease in HIV-specific TGF-beta positive and IL-10 positive CD8+ T cell responses, and a concomitant increase in HIV-specific IFN-gamma positive CD8+ T cell responses. Depletion of CD4+ T cells abrogated the impact of CTLA-4 on HIV-specific TGF-beta positive and IL-10 positive CD8+ T cells. Our study suggests that CTLA-4 Signaling on CD4+ T cells regulates the inhibitory functions of the HIV-specific suppressor CD8+ T cells.
Antiretrovirals to CCR5 CRISPR/Cas9 gene editing - A paradigm shift chasing an HIV cure.
Khan A, Paneerselvam N, Lawson B Clin Immunol. 2023; 255:109741.
PMID: 37611838 PMC: 10631514. DOI: 10.1016/j.clim.2023.109741.
Rasquel-Oliveira F, da Silva M, Martelossi-Cebinelli G, Fattori V, Casagrande R, Verri Jr W Molecules. 2023; 28(13).
PMID: 37446699 PMC: 10343836. DOI: 10.3390/molecules28135032.
Jackson S, Sedikides G, Romashova V, Okecha G, Remmerswaal E, Bemelman F Pathogens. 2022; 11(12).
PMID: 36558866 PMC: 9781655. DOI: 10.3390/pathogens11121530.
Lin W, Kuo Y, Chen C, Huang Y, Hsu C, Lin J Curr Microbiol. 2021; 78(9):3541-3549.
PMID: 34345965 PMC: 8363536. DOI: 10.1007/s00284-021-02569-8.
Lien K, Mayer W, Herrera R, Rosbe K, Tugizov S PLoS One. 2019; 14(12):e0226343.
PMID: 31869348 PMC: 6927651. DOI: 10.1371/journal.pone.0226343.